HighCape Partners GP II, LLC - 22 Dec 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
10%+ Owner
Signature
HighCape Partners GP II, LLC By: /s/ W. Matthew Zuga Name: W. Matthew Zuga Title: Managing Member
Issuer symbol
ELUT
Transactions as of
22 Dec 2022
Net transactions value
$0
Form type
4
Filing time
28 Dec 2022, 14:55:35 UTC
Previous filing
15 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZYO Stock Option (Right to Buy) Award $0 +17,533 $0.000000 17,533 22 Dec 2022 Class A Common Stock 17,533 $3.80 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.
F2 Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.

Remarks:

Due to the limitations of the electronic filing system, each of HighCape Capital, L.P., HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, W. Matthew Zuga and Kevin L. Rakin filed on a separate Form 4 dated December 27, 2022.